Abstract TP407: Participant Satisfaction With a Lifestyle Management Program in the SAMMPRIS Clinical Trial
Background: SAMMPRIS was the first secondary prevention stroke trial to provide a lifestyle modification program to all clinical trial participants. We sought to determine if SAMMPRIS participants would have a high level of satisfaction with the compulsory lifestyle program.
Methods: Patients enrolled in SAMMPRIS who were actively participating in the lifestyle modification program for > 12 weeks were mailed anonymous surveys. The survey was conducted by the company that administered the lifestyle program and the data was provided to the authors. The survey measured 6 constructs: consistency of program delivery, quality of materials, confidentiality, coach-participant relationship, individualization, and time efficiency, with 2 statements addressing each construct. Participants were asked to respond to 2 variables, “importance” and “satisfaction”, for each statement using five-point Likert-type scales (5 = high; 1 = low). An adjusted needs index (ANI) was computed for each statement: [(mean importance - mean satisfaction) x (mean importance)]. Participants were also asked to respond (“strongly agree” or “strongly disagree”) to 2 statements related to their overall evaluation of the program and if they would recommend the program to others.
Results: Surveys were completed by 199/327 (61%) participants. For the 6 constructs, mean scores for “importance” ranged from 4.36 - 4.73 and mean scores for “satisfaction” ranged from 4.38 - 4.69. The coach-participant relationship rated highest for both “importance” and “satisfaction”. ANIs for 8 of 12 statements were either 0 or negative values, indicating that expectations were met or exceeded. Individualization of the program had the highest ANI at 0.45. Statements regarding overall evaluation received high ratings (means 4.65, 4.66).
Conclusion: SAMMPRIS clinical trial participants had a high level of satisfaction with the study’s lifestyle management program. These data, coupled with final data from SAMMPRIS showing that compliance with the program resulted in improved control of risk factors, would strongly support the use of lifestyle programs in future stroke prevention clinical trials and in clinical practice.
- Risk factors
- Cerebrovascular circulation
- Patient education/teaching psychosocial aspects
- Healthcare delivery systems
- © 2012 by American Heart Association, Inc.